dearseq: a variance component score test for RNA-Seq differential analysis that effectively controls the false discovery rate - Inria - Institut national de recherche en sciences et technologies du numérique
Article Dans Une Revue NAR Genomics and Bioinformatics Année : 2020

dearseq: a variance component score test for RNA-Seq differential analysis that effectively controls the false discovery rate

Résumé

RNA-seq studies are growing in size and popularity. We provide evidence that the most commonly used methods for differential expression analysis (DEA) may yield too many false positive results in some situations. We present dearseq, a new method for DEA which controls the FDR without making any assumption about the true distribution of RNA-seq data. We show that dearseq controls the FDR while maintaining strong statistical power compared to the most popular methods. We demonstrate this behavior with mathematical proofs, simulations, and a real data set from a study of Tuberculosis, where our method produces fewer apparent false positives.
Fichier principal
Vignette du fichier
635714.full.pdf (1.89 Mo) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

hal-02138664 , version 1 (24-05-2019)

Identifiants

Citer

Marine Gauthier, Denis Agniel, Rodolphe Thiébaut, Boris Hejblum. dearseq: a variance component score test for RNA-Seq differential analysis that effectively controls the false discovery rate. NAR Genomics and Bioinformatics, 2020, 2 (4), pp.lqaa093. ⟨10.1093/nargab/lqaa093⟩. ⟨hal-02138664⟩
197 Consultations
486 Téléchargements

Altmetric

Partager

More